ROBBINS WENDYE purchased 333.3% of their position (5K shares) of RAPT THERAPEUTICS, INC. on the open market
Open‑market purchase worth $97.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 3/15/2023ACC: 0001209191-23-019023
+5K
Net shares
Net buyer
$97.6K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
5K acquired
Non-Derivative Transactions4
Common Stock
Direct
Shares
+1.50K
Price / share
$18.75
Trade value
$28.13K
% of position
12.1%
3/14/2023
12.40K→13.90K
Common Stock
Direct
Shares
+400.00
Price / share
$18.48
Trade value
$7.39K
% of position
2.9%
3/14/2023
13.90K→14.30K
Common Stock
Direct
Shares
+600.00
Price / share
$19.95
Trade value
$11.97K
% of position
4.2%
3/14/2023
14.30K→14.90K
Common Stock
Indirect
Shares
+2.50K
Price / share
$20.05
Trade value
$50.13K
% of position
62.5%
3/14/2023
4K→6.50K
Total
Net shares
+5K
Net value
$97.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/14/2023 | P · Purchase | +1.50K | $18.75 | $28.13K | 12.1% | 12.40K | 13.90K |
| Common Stock Direct | 3/14/2023 | P · Purchase | +400.00 | $18.48 | $7.39K | 2.9% | 13.90K | 14.30K |
| Common Stock Direct | 3/14/2023 | P · Purchase | +600.00 | $19.95 | $11.97K | 4.2% | 14.30K | 14.90K |
| Common Stock Indirect | 3/14/2023 | P · Purchase | +2.50K | $20.05 | $50.13K | 62.5% | 4K | 6.50K |
| Total | +5K | $97.61K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.10K
Total
6.10K indirect6.10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.10K | Indirect |
| Total | 6.10K | 6.10K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported